arrow
M

Michael T. Bigham

pennsylvania commonwealth system of higher education (pcshe)
H指数:33
被引数:3,830

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

External Validation, Molecular Signatures, and Therapeutic Relevance of Pediatric Sepsis-Associated Acute Kidney Injury Subphenotypes

儿科脓毒症相关性急性肾损伤亚型的外部验证、分子特征及其治疗相关性

2026-05-220
PRE
Neutrophil dysregulation differentiates pediatric septic shock biomarker-based mortality-risk strata: insights from weighted gene co-expression network and transcriptomic analyses

中性粒细胞失调可区分儿科脓毒性休克基于生物标志物的死亡风险分层:加权基因共表达网络和转录组学分析的见解

2025-11-190
OAAI
Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes
2024-07-170
OAAI
External validation of the modified sepsis renal angina index for prediction of severe acute kidney injury in children with septic shock

改良脓毒症肾绞痛指数预测脓毒症休克患儿严重急性肾损伤的外部验证

2023-11-282
OAAI
Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock
2023-07-0315
OAAI
Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1
2023-06-262
OAAI
Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study
2022-07-1116
OAAI
PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock
2020-04-0151
OAAI
Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model

儿童脓毒症生物标志物风险模型的前瞻性临床测试和实验验证

2019-11-1350
OAAI
Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response
2018-03-0145
OAAI